| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neoplasms | 15 | 2025 | 1341 | 3.830 |
Why?
|
| Colorectal Neoplasms | 5 | 2024 | 502 | 2.390 |
Why?
|
| Lung Neoplasms | 7 | 2024 | 479 | 1.900 |
Why?
|
| Emergency Service, Hospital | 6 | 2025 | 268 | 1.820 |
Why?
|
| Registries | 7 | 2025 | 431 | 1.720 |
Why?
|
| Electronic Health Records | 7 | 2023 | 99 | 1.240 |
Why?
|
| SEER Program | 7 | 2024 | 157 | 1.170 |
Why?
|
| Healthcare Disparities | 7 | 2025 | 573 | 1.160 |
Why?
|
| Visual Cortex | 4 | 2025 | 65 | 1.130 |
Why?
|
| Humans | 87 | 2025 | 42163 | 1.110 |
Why?
|
| Breast Neoplasms | 9 | 2025 | 1679 | 1.100 |
Why?
|
| United States | 23 | 2025 | 5072 | 1.090 |
Why?
|
| Aged | 41 | 2025 | 7982 | 1.050 |
Why?
|
| Medicare | 5 | 2025 | 326 | 0.990 |
Why?
|
| Female | 63 | 2025 | 24018 | 0.980 |
Why?
|
| Insurance Claim Review | 1 | 2025 | 35 | 0.900 |
Why?
|
| Poverty | 2 | 2024 | 395 | 0.850 |
Why?
|
| Male | 47 | 2025 | 22779 | 0.850 |
Why?
|
| Housing | 1 | 2024 | 68 | 0.830 |
Why?
|
| Middle Aged | 41 | 2025 | 11819 | 0.820 |
Why?
|
| Aged, 80 and over | 19 | 2025 | 2803 | 0.800 |
Why?
|
| Social Class | 3 | 2022 | 286 | 0.800 |
Why?
|
| Thyroid Neoplasms | 1 | 2023 | 49 | 0.760 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2024 | 471 | 0.740 |
Why?
|
| California | 10 | 2025 | 531 | 0.720 |
Why?
|
| Hospitals | 7 | 2015 | 115 | 0.720 |
Why?
|
| Adult | 38 | 2025 | 13458 | 0.710 |
Why?
|
| Rural Population | 1 | 2024 | 352 | 0.710 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2022 | 130 | 0.680 |
Why?
|
| Emigrants and Immigrants | 1 | 2021 | 156 | 0.610 |
Why?
|
| Incidence | 11 | 2025 | 1054 | 0.610 |
Why?
|
| Age of Onset | 3 | 2024 | 115 | 0.570 |
Why?
|
| Death Certificates | 1 | 2018 | 15 | 0.560 |
Why?
|
| Maternal Exposure | 1 | 2018 | 56 | 0.550 |
Why?
|
| Smoking | 4 | 2022 | 1019 | 0.540 |
Why?
|
| Pre-Eclampsia | 1 | 2018 | 68 | 0.530 |
Why?
|
| Mexican Americans | 1 | 2019 | 224 | 0.520 |
Why?
|
| Premature Birth | 1 | 2018 | 94 | 0.510 |
Why?
|
| Pregnancy Complications | 1 | 2018 | 134 | 0.510 |
Why?
|
| Selection Bias | 2 | 2022 | 13 | 0.490 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2014 | 350 | 0.480 |
Why?
|
| Early Detection of Cancer | 2 | 2024 | 428 | 0.480 |
Why?
|
| Arthroplasty, Replacement, Knee | 3 | 2020 | 14 | 0.480 |
Why?
|
| Prostatic Neoplasms | 2 | 2024 | 1068 | 0.450 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 744 | 0.450 |
Why?
|
| Epidemiologic Research Design | 1 | 2014 | 18 | 0.440 |
Why?
|
| Health Status Disparities | 5 | 2021 | 705 | 0.440 |
Why?
|
| Quality Assurance, Health Care | 4 | 2015 | 56 | 0.430 |
Why?
|
| Patient Compliance | 2 | 2015 | 225 | 0.420 |
Why?
|
| Sex Factors | 5 | 2024 | 1008 | 0.420 |
Why?
|
| Home Care Services | 1 | 2014 | 37 | 0.410 |
Why?
|
| Oropharyngeal Neoplasms | 2 | 2024 | 10 | 0.410 |
Why?
|
| Disease Management | 1 | 2014 | 68 | 0.410 |
Why?
|
| Diabetes Complications | 1 | 2014 | 99 | 0.400 |
Why?
|
| Wound Healing | 1 | 2014 | 82 | 0.400 |
Why?
|
| Cuba | 2 | 2024 | 31 | 0.380 |
Why?
|
| Wounds and Injuries | 1 | 2014 | 191 | 0.370 |
Why?
|
| Melanoma | 1 | 2013 | 109 | 0.370 |
Why?
|
| Risk Factors | 10 | 2021 | 3942 | 0.350 |
Why?
|
| Skin Neoplasms | 1 | 2013 | 175 | 0.350 |
Why?
|
| Work Schedule Tolerance | 1 | 2010 | 4 | 0.340 |
Why?
|
| Age Factors | 4 | 2024 | 1139 | 0.340 |
Why?
|
| Lighting | 1 | 2010 | 12 | 0.340 |
Why?
|
| North Carolina | 3 | 2025 | 122 | 0.330 |
Why?
|
| Geological Phenomena | 1 | 2010 | 4 | 0.330 |
Why?
|
| Substance-Related Disorders | 1 | 2018 | 825 | 0.330 |
Why?
|
| Occupational Diseases | 1 | 2010 | 53 | 0.330 |
Why?
|
| Geologic Sediments | 1 | 2010 | 47 | 0.320 |
Why?
|
| Rivers | 1 | 2010 | 50 | 0.320 |
Why?
|
| Health Services Accessibility | 2 | 2025 | 680 | 0.310 |
Why?
|
| Phosphorus | 1 | 2010 | 65 | 0.310 |
Why?
|
| Cross-Cultural Comparison | 2 | 2014 | 109 | 0.310 |
Why?
|
| Retrospective Studies | 7 | 2023 | 2485 | 0.310 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2021 | 158 | 0.290 |
Why?
|
| Critical Illness | 3 | 2019 | 46 | 0.290 |
Why?
|
| Liver Neoplasms | 2 | 2021 | 211 | 0.280 |
Why?
|
| Neoplasm Staging | 3 | 2024 | 366 | 0.280 |
Why?
|
| Water | 1 | 2010 | 314 | 0.270 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2019 | 164 | 0.260 |
Why?
|
| Survivors | 2 | 2019 | 152 | 0.250 |
Why?
|
| Peer Group | 2 | 2019 | 173 | 0.240 |
Why?
|
| Cohort Studies | 7 | 2025 | 1729 | 0.240 |
Why?
|
| Patients | 2 | 2016 | 16 | 0.240 |
Why?
|
| Survival Rate | 2 | 2019 | 353 | 0.230 |
Why?
|
| Safety Management | 2 | 2015 | 16 | 0.230 |
Why?
|
| Young Adult | 11 | 2021 | 4936 | 0.220 |
Why?
|
| Marital Status | 1 | 2024 | 46 | 0.220 |
Why?
|
| Critical Pathways | 2 | 2014 | 18 | 0.220 |
Why?
|
| Algorithms | 2 | 2025 | 508 | 0.220 |
Why?
|
| Endometrial Neoplasms | 2 | 2015 | 79 | 0.220 |
Why?
|
| Social Support | 2 | 2019 | 438 | 0.220 |
Why?
|
| Nerve Net | 1 | 2025 | 96 | 0.210 |
Why?
|
| Forecasting | 1 | 2024 | 136 | 0.210 |
Why?
|
| Proportional Hazards Models | 5 | 2024 | 512 | 0.200 |
Why?
|
| Epidemiologic Methods | 1 | 2023 | 56 | 0.200 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2023 | 14 | 0.200 |
Why?
|
| Teaching | 1 | 2003 | 58 | 0.200 |
Why?
|
| Attitude of Health Personnel | 2 | 2014 | 222 | 0.200 |
Why?
|
| Hospital Administration | 4 | 2015 | 9 | 0.190 |
Why?
|
| Air Pollution | 1 | 2023 | 87 | 0.190 |
Why?
|
| Europe | 7 | 2015 | 114 | 0.190 |
Why?
|
| Prejudice | 1 | 2003 | 116 | 0.190 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2022 | 54 | 0.190 |
Why?
|
| Nursing Staff, Hospital | 2 | 2014 | 19 | 0.190 |
Why?
|
| Basal Ganglia | 1 | 2022 | 20 | 0.190 |
Why?
|
| Hallucinogens | 1 | 2022 | 29 | 0.190 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2003 | 93 | 0.190 |
Why?
|
| Prospective Studies | 7 | 2025 | 1574 | 0.190 |
Why?
|
| Air Pollutants | 1 | 2023 | 127 | 0.190 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2022 | 63 | 0.180 |
Why?
|
| Neurons | 3 | 2025 | 1246 | 0.180 |
Why?
|
| Neurogenesis | 1 | 2022 | 64 | 0.180 |
Why?
|
| Comorbidity | 1 | 2024 | 725 | 0.180 |
Why?
|
| Marijuana Smoking | 1 | 2022 | 90 | 0.180 |
Why?
|
| Head and Neck Neoplasms | 1 | 2022 | 81 | 0.170 |
Why?
|
| Hypoglycemic Agents | 1 | 2023 | 181 | 0.170 |
Why?
|
| Age Distribution | 1 | 2021 | 249 | 0.170 |
Why?
|
| Cannabis | 1 | 2022 | 90 | 0.170 |
Why?
|
| Mortality | 2 | 2019 | 174 | 0.170 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2015 | 959 | 0.170 |
Why?
|
| Adolescent | 9 | 2022 | 5950 | 0.170 |
Why?
|
| Validation Studies as Topic | 1 | 2020 | 8 | 0.160 |
Why?
|
| Hospitalization | 3 | 2019 | 482 | 0.160 |
Why?
|
| Population Surveillance | 1 | 2021 | 245 | 0.160 |
Why?
|
| Postoperative Complications | 2 | 2015 | 253 | 0.160 |
Why?
|
| Veterans | 1 | 2022 | 203 | 0.160 |
Why?
|
| Arthralgia | 1 | 2019 | 12 | 0.160 |
Why?
|
| Osteoarthritis, Knee | 1 | 2019 | 14 | 0.160 |
Why?
|
| Mobility Limitation | 1 | 2019 | 21 | 0.160 |
Why?
|
| South America | 1 | 2019 | 22 | 0.160 |
Why?
|
| Mice | 5 | 2025 | 6490 | 0.150 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2019 | 53 | 0.150 |
Why?
|
| Action Potentials | 1 | 2021 | 246 | 0.150 |
Why?
|
| Visual Pathways | 1 | 2019 | 40 | 0.150 |
Why?
|
| Soft Tissue Infections | 1 | 2018 | 6 | 0.150 |
Why?
|
| Cross-Sectional Studies | 9 | 2022 | 3077 | 0.150 |
Why?
|
| Quality Control | 2 | 2015 | 41 | 0.150 |
Why?
|
| Clinical Competence | 2 | 2014 | 154 | 0.150 |
Why?
|
| Organizational Culture | 2 | 2015 | 15 | 0.150 |
Why?
|
| Mammography | 2 | 2024 | 211 | 0.150 |
Why?
|
| Aorta, Thoracic | 1 | 2018 | 31 | 0.150 |
Why?
|
| Brain Mapping | 1 | 2019 | 132 | 0.140 |
Why?
|
| Reward | 2 | 2016 | 106 | 0.140 |
Why?
|
| Aortic Diseases | 1 | 2018 | 34 | 0.140 |
Why?
|
| Lymphocyte Count | 1 | 2018 | 47 | 0.140 |
Why?
|
| Cause of Death | 2 | 2018 | 183 | 0.140 |
Why?
|
| Ultrasonography | 1 | 2018 | 132 | 0.140 |
Why?
|
| Educational Status | 2 | 2013 | 335 | 0.140 |
Why?
|
| Quality of Life | 2 | 2019 | 599 | 0.140 |
Why?
|
| Medical Staff, Hospital | 2 | 2015 | 15 | 0.140 |
Why?
|
| Weight Gain | 2 | 2015 | 138 | 0.140 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 92 | 0.140 |
Why?
|
| Continuity of Patient Care | 1 | 2019 | 118 | 0.140 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2019 | 358 | 0.140 |
Why?
|
| Pilot Projects | 3 | 2015 | 733 | 0.130 |
Why?
|
| Survival Analysis | 3 | 2013 | 362 | 0.130 |
Why?
|
| Alzheimer Disease | 1 | 2024 | 972 | 0.130 |
Why?
|
| Contracts | 1 | 2016 | 1 | 0.130 |
Why?
|
| Drug Synergism | 1 | 2017 | 189 | 0.130 |
Why?
|
| Internet | 2 | 2016 | 234 | 0.130 |
Why?
|
| Patient Participation | 2 | 2015 | 87 | 0.130 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 1058 | 0.120 |
Why?
|
| Drug Monitoring | 1 | 2016 | 20 | 0.120 |
Why?
|
| Sex Distribution | 1 | 2016 | 224 | 0.120 |
Why?
|
| Cost of Illness | 1 | 2016 | 95 | 0.120 |
Why?
|
| Critical Care | 1 | 2016 | 48 | 0.120 |
Why?
|
| Carboxypeptidase H | 1 | 2015 | 6 | 0.120 |
Why?
|
| Risk Assessment | 2 | 2024 | 845 | 0.120 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2015 | 16 | 0.120 |
Why?
|
| Stroke | 3 | 2015 | 348 | 0.120 |
Why?
|
| Hospital Charges | 1 | 2015 | 15 | 0.120 |
Why?
|
| Leiomyosarcoma | 1 | 2015 | 3 | 0.120 |
Why?
|
| Obesity, Morbid | 1 | 2015 | 29 | 0.120 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2015 | 59 | 0.120 |
Why?
|
| Hysterectomy | 1 | 2015 | 39 | 0.120 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 2015 | 12 | 0.120 |
Why?
|
| Reminder Systems | 1 | 2015 | 15 | 0.120 |
Why?
|
| Cooperative Behavior | 2 | 2015 | 250 | 0.120 |
Why?
|
| Mental Health | 1 | 2019 | 363 | 0.120 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2015 | 27 | 0.120 |
Why?
|
| Laparoscopy | 1 | 2015 | 59 | 0.120 |
Why?
|
| Pregnancy | 2 | 2018 | 1737 | 0.120 |
Why?
|
| Logistic Models | 2 | 2017 | 1001 | 0.120 |
Why?
|
| Appointments and Schedules | 1 | 2015 | 27 | 0.110 |
Why?
|
| Contraceptive Agents, Female | 1 | 2015 | 25 | 0.110 |
Why?
|
| Central Nervous System Diseases | 1 | 2015 | 32 | 0.110 |
Why?
|
| Infant, Newborn | 1 | 2018 | 960 | 0.110 |
Why?
|
| Pregnancy in Adolescence | 1 | 2015 | 34 | 0.110 |
Why?
|
| San Francisco | 1 | 2014 | 34 | 0.110 |
Why?
|
| Binomial Distribution | 1 | 2014 | 1 | 0.110 |
Why?
|
| Colonography, Computed Tomographic | 1 | 2014 | 23 | 0.110 |
Why?
|
| Occult Blood | 1 | 2014 | 32 | 0.110 |
Why?
|
| Puerto Rico | 1 | 2019 | 1376 | 0.110 |
Why?
|
| Obesity | 2 | 2015 | 1131 | 0.110 |
Why?
|
| Animals | 6 | 2025 | 16695 | 0.110 |
Why?
|
| Uterine Neoplasms | 1 | 2015 | 51 | 0.110 |
Why?
|
| Papillomaviridae | 2 | 2006 | 136 | 0.110 |
Why?
|
| Hospital Administrators | 1 | 2014 | 2 | 0.110 |
Why?
|
| Probability | 1 | 2014 | 82 | 0.110 |
Why?
|
| Communication Barriers | 1 | 2014 | 60 | 0.110 |
Why?
|
| Proxy | 1 | 2014 | 7 | 0.110 |
Why?
|
| Health Status | 2 | 2018 | 432 | 0.110 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2015 | 83 | 0.110 |
Why?
|
| Evidence-Based Nursing | 1 | 2014 | 2 | 0.110 |
Why?
|
| Patient Discharge | 3 | 2019 | 131 | 0.110 |
Why?
|
| Checklist | 1 | 2014 | 16 | 0.110 |
Why?
|
| Longitudinal Studies | 2 | 2014 | 1020 | 0.110 |
Why?
|
| Colonoscopy | 1 | 2014 | 117 | 0.110 |
Why?
|
| Gene Expression | 1 | 2017 | 692 | 0.110 |
Why?
|
| Evidence-Based Practice | 1 | 2014 | 48 | 0.110 |
Why?
|
| Nurses | 1 | 2014 | 55 | 0.100 |
Why?
|
| Developed Countries | 1 | 2013 | 15 | 0.100 |
Why?
|
| Quality Indicators, Health Care | 1 | 2014 | 49 | 0.100 |
Why?
|
| Rural Health | 1 | 2014 | 55 | 0.100 |
Why?
|
| Cerebral Ventricles | 1 | 2013 | 23 | 0.100 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2013 | 25 | 0.100 |
Why?
|
| Birth Rate | 1 | 2013 | 6 | 0.100 |
Why?
|
| Time Factors | 3 | 2024 | 1848 | 0.100 |
Why?
|
| Child Mortality | 1 | 2013 | 11 | 0.100 |
Why?
|
| Physician-Patient Relations | 1 | 2014 | 146 | 0.100 |
Why?
|
| Cultural Competency | 1 | 2014 | 137 | 0.100 |
Why?
|
| Maternal Mortality | 1 | 2013 | 26 | 0.100 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 73 | 0.100 |
Why?
|
| Exercise | 1 | 2019 | 674 | 0.100 |
Why?
|
| Leadership | 1 | 2013 | 84 | 0.100 |
Why?
|
| Monte Carlo Method | 1 | 2013 | 66 | 0.100 |
Why?
|
| Developing Countries | 1 | 2013 | 112 | 0.100 |
Why?
|
| Aging | 1 | 2018 | 764 | 0.100 |
Why?
|
| Referral and Consultation | 1 | 2014 | 141 | 0.100 |
Why?
|
| Selective Estrogen Receptor Modulators | 1 | 2013 | 31 | 0.100 |
Why?
|
| Language | 1 | 2014 | 181 | 0.100 |
Why?
|
| Austria | 1 | 2012 | 5 | 0.100 |
Why?
|
| Prognosis | 3 | 2022 | 850 | 0.100 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 1221 | 0.100 |
Why?
|
| Causality | 1 | 2012 | 45 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2019 | 729 | 0.100 |
Why?
|
| Motivation | 1 | 2016 | 492 | 0.100 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 683 | 0.090 |
Why?
|
| Kidney Neoplasms | 1 | 2013 | 77 | 0.090 |
Why?
|
| Physicians | 1 | 2014 | 180 | 0.090 |
Why?
|
| Cerebral Hemorrhage | 1 | 2013 | 115 | 0.090 |
Why?
|
| Analgesics, Opioid | 2 | 2011 | 245 | 0.090 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 2011 | 3 | 0.090 |
Why?
|
| Research Design | 1 | 2014 | 370 | 0.090 |
Why?
|
| Peptic Ulcer | 1 | 2011 | 15 | 0.090 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 2011 | 1 | 0.090 |
Why?
|
| Embolization, Therapeutic | 1 | 2011 | 23 | 0.090 |
Why?
|
| Naloxone | 1 | 2011 | 56 | 0.090 |
Why?
|
| Pain, Postoperative | 1 | 2011 | 28 | 0.090 |
Why?
|
| Indoles | 1 | 2013 | 178 | 0.090 |
Why?
|
| Narcotic Antagonists | 1 | 2011 | 78 | 0.090 |
Why?
|
| Intensive Care Units | 3 | 2019 | 71 | 0.090 |
Why?
|
| Morphine | 1 | 2011 | 68 | 0.090 |
Why?
|
| Kidney Transplantation | 2 | 2015 | 102 | 0.090 |
Why?
|
| Moving and Lifting Patients | 1 | 2010 | 1 | 0.080 |
Why?
|
| Dexmedetomidine | 1 | 2010 | 2 | 0.080 |
Why?
|
| Health Behavior | 1 | 2014 | 568 | 0.080 |
Why?
|
| Acrylates | 1 | 2010 | 8 | 0.080 |
Why?
|
| Conscious Sedation | 1 | 2010 | 7 | 0.080 |
Why?
|
| Health Promotion | 1 | 2016 | 691 | 0.080 |
Why?
|
| Fentanyl | 1 | 2010 | 16 | 0.080 |
Why?
|
| Hypnotics and Sedatives | 1 | 2010 | 27 | 0.080 |
Why?
|
| Stress, Psychological | 1 | 2016 | 641 | 0.080 |
Why?
|
| Respiration | 1 | 2009 | 56 | 0.080 |
Why?
|
| Oxygen Consumption | 1 | 2009 | 111 | 0.080 |
Why?
|
| Physical Fitness | 1 | 2009 | 93 | 0.080 |
Why?
|
| Exercise Therapy | 1 | 2009 | 83 | 0.080 |
Why?
|
| Walking | 1 | 2009 | 85 | 0.070 |
Why?
|
| Circadian Rhythm | 1 | 2010 | 234 | 0.070 |
Why?
|
| Texas | 1 | 2010 | 428 | 0.070 |
Why?
|
| Child, Preschool | 3 | 2018 | 1516 | 0.070 |
Why?
|
| Education, Nursing, Graduate | 1 | 2006 | 4 | 0.070 |
Why?
|
| Nursing | 1 | 2006 | 5 | 0.070 |
Why?
|
| Pain | 1 | 2009 | 283 | 0.060 |
Why?
|
| Odds Ratio | 3 | 2013 | 587 | 0.060 |
Why?
|
| Mouth | 1 | 2006 | 49 | 0.060 |
Why?
|
| Cognition | 1 | 2010 | 458 | 0.060 |
Why?
|
| Liver Transplantation | 1 | 2006 | 37 | 0.060 |
Why?
|
| Diabetes Mellitus | 2 | 2015 | 532 | 0.060 |
Why?
|
| Analysis of Variance | 3 | 2014 | 574 | 0.060 |
Why?
|
| Hip Fractures | 2 | 2015 | 29 | 0.060 |
Why?
|
| Atlases as Topic | 1 | 2024 | 7 | 0.060 |
Why?
|
| Temporal Lobe | 1 | 2024 | 24 | 0.060 |
Why?
|
| Delayed Diagnosis | 1 | 2024 | 33 | 0.060 |
Why?
|
| Curriculum | 2 | 2006 | 311 | 0.060 |
Why?
|
| Australia | 1 | 2004 | 95 | 0.050 |
Why?
|
| Neural Pathways | 1 | 2025 | 139 | 0.050 |
Why?
|
| European Union | 2 | 2014 | 6 | 0.050 |
Why?
|
| Turkey | 2 | 2014 | 23 | 0.050 |
Why?
|
| Quality of Health Care | 1 | 2025 | 158 | 0.050 |
Why?
|
| Models, Neurological | 1 | 2025 | 135 | 0.050 |
Why?
|
| Risk | 1 | 2024 | 289 | 0.050 |
Why?
|
| China | 1 | 2004 | 233 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2025 | 336 | 0.050 |
Why?
|
| Research Personnel | 1 | 2025 | 191 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2023 | 1266 | 0.050 |
Why?
|
| Contraception | 1 | 2004 | 60 | 0.050 |
Why?
|
| Papillomavirus Infections | 2 | 2006 | 363 | 0.050 |
Why?
|
| New Zealand | 1 | 2003 | 31 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2024 | 150 | 0.050 |
Why?
|
| Infant | 2 | 2018 | 1143 | 0.050 |
Why?
|
| Respiration, Artificial | 2 | 2015 | 47 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2013 | 1586 | 0.050 |
Why?
|
| Child | 3 | 2018 | 3381 | 0.050 |
Why?
|
| Particulate Matter | 1 | 2023 | 80 | 0.050 |
Why?
|
| Myocardial Infarction | 2 | 2015 | 242 | 0.050 |
Why?
|
| Astrocytes | 1 | 2024 | 244 | 0.050 |
Why?
|
| Microglia | 1 | 2024 | 204 | 0.050 |
Why?
|
| Ambulatory Care | 1 | 2023 | 81 | 0.050 |
Why?
|
| Propensity Score | 1 | 2022 | 58 | 0.050 |
Why?
|
| Breast | 1 | 2023 | 139 | 0.050 |
Why?
|
| Nomograms | 1 | 2022 | 14 | 0.050 |
Why?
|
| Body Weight | 2 | 2015 | 428 | 0.050 |
Why?
|
| Disease Progression | 1 | 2024 | 661 | 0.050 |
Why?
|
| Genotype | 1 | 2004 | 796 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2003 | 358 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2022 | 104 | 0.040 |
Why?
|
| Regression Analysis | 2 | 2013 | 487 | 0.040 |
Why?
|
| Medical Record Linkage | 1 | 2021 | 16 | 0.040 |
Why?
|
| Environmental Exposure | 1 | 2023 | 247 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2013 | 305 | 0.040 |
Why?
|
| Thalamus | 1 | 2021 | 34 | 0.040 |
Why?
|
| Nurse's Role | 2 | 2014 | 35 | 0.040 |
Why?
|
| Electrophysiology | 1 | 2021 | 138 | 0.040 |
Why?
|
| Photic Stimulation | 1 | 2021 | 123 | 0.040 |
Why?
|
| Pain Measurement | 2 | 2011 | 181 | 0.040 |
Why?
|
| Disability Evaluation | 1 | 2020 | 74 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 708 | 0.040 |
Why?
|
| Skilled Nursing Facilities | 1 | 2019 | 20 | 0.040 |
Why?
|
| Public Opinion | 1 | 2019 | 20 | 0.040 |
Why?
|
| Censuses | 1 | 2019 | 28 | 0.040 |
Why?
|
| Happiness | 1 | 2019 | 15 | 0.040 |
Why?
|
| Mass Screening | 1 | 2024 | 531 | 0.040 |
Why?
|
| Women | 1 | 2019 | 28 | 0.040 |
Why?
|
| Semantics | 1 | 2019 | 29 | 0.040 |
Why?
|
| Sexual Behavior | 1 | 2004 | 634 | 0.040 |
Why?
|
| Cities | 1 | 2019 | 78 | 0.040 |
Why?
|
| Aortography | 1 | 2018 | 10 | 0.040 |
Why?
|
| Physical Examination | 1 | 2018 | 45 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2018 | 35 | 0.040 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 25 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 236 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2019 | 120 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2022 | 722 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 233 | 0.030 |
Why?
|
| Syndrome | 1 | 2016 | 73 | 0.030 |
Why?
|
| Calibration | 1 | 2016 | 62 | 0.030 |
Why?
|
| Minisatellite Repeats | 1 | 2015 | 18 | 0.030 |
Why?
|
| Lymphedema | 1 | 2015 | 7 | 0.030 |
Why?
|
| Urinary Tract | 1 | 2015 | 8 | 0.030 |
Why?
|
| Neoplasm Seeding | 1 | 2015 | 5 | 0.030 |
Why?
|
| Glucocorticoids | 1 | 2016 | 92 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2015 | 30 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 1804 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2016 | 94 | 0.030 |
Why?
|
| Injections, Intramuscular | 1 | 2015 | 21 | 0.030 |
Why?
|
| Surgical Wound Infection | 1 | 2015 | 22 | 0.030 |
Why?
|
| Gynecologic Surgical Procedures | 1 | 2015 | 8 | 0.030 |
Why?
|
| Delivery, Obstetric | 1 | 2015 | 48 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 118 | 0.030 |
Why?
|
| Family Planning Services | 1 | 2015 | 34 | 0.030 |
Why?
|
| Gastrointestinal Tract | 1 | 2015 | 67 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 2015 | 43 | 0.030 |
Why?
|
| Robotics | 1 | 2015 | 42 | 0.030 |
Why?
|
| Hospital Departments | 1 | 2014 | 3 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2015 | 163 | 0.030 |
Why?
|
| Energy Intake | 1 | 2015 | 162 | 0.030 |
Why?
|
| Length of Stay | 1 | 2015 | 231 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 170 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2015 | 110 | 0.030 |
Why?
|
| Genomics | 1 | 2016 | 289 | 0.030 |
Why?
|
| Physician's Role | 1 | 2014 | 39 | 0.030 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2013 | 2 | 0.030 |
Why?
|
| Maternal Welfare | 1 | 2013 | 7 | 0.030 |
Why?
|
| Population Growth | 1 | 2013 | 8 | 0.030 |
Why?
|
| Thrombolytic Therapy | 1 | 2013 | 25 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2014 | 98 | 0.030 |
Why?
|
| Data Collection | 1 | 2014 | 210 | 0.030 |
Why?
|
| Africa | 1 | 2013 | 81 | 0.030 |
Why?
|
| Goals | 1 | 2013 | 33 | 0.030 |
Why?
|
| Suicide | 1 | 2015 | 139 | 0.030 |
Why?
|
| Carcinogenicity Tests | 1 | 2013 | 5 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 309 | 0.030 |
Why?
|
| Urban Population | 1 | 2015 | 364 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2016 | 410 | 0.020 |
Why?
|
| Adolescent Behavior | 1 | 2015 | 270 | 0.020 |
Why?
|
| Retreatment | 1 | 2011 | 10 | 0.020 |
Why?
|
| Pruritus | 1 | 2011 | 4 | 0.020 |
Why?
|
| Antipruritics | 1 | 2011 | 3 | 0.020 |
Why?
|
| Antiemetics | 1 | 2011 | 8 | 0.020 |
Why?
|
| Health Surveys | 1 | 2013 | 401 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 727 | 0.020 |
Why?
|
| Infusions, Intravenous | 1 | 2011 | 55 | 0.020 |
Why?
|
| Vomiting | 1 | 2011 | 14 | 0.020 |
Why?
|
| Nausea | 1 | 2011 | 13 | 0.020 |
Why?
|
| Eating | 1 | 2013 | 164 | 0.020 |
Why?
|
| Baltimore | 1 | 2011 | 58 | 0.020 |
Why?
|
| Health Policy | 1 | 2013 | 184 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2015 | 860 | 0.020 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2011 | 140 | 0.020 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2013 | 188 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2010 | 112 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2011 | 230 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 174 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 438 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2010 | 281 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 1051 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 1597 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 1112 | 0.020 |
Why?
|
| Professional Practice | 1 | 2006 | 6 | 0.020 |
Why?
|
| Faculty, Nursing | 1 | 2006 | 5 | 0.020 |
Why?
|
| Organizational Innovation | 1 | 2006 | 21 | 0.020 |
Why?
|
| Liver Diseases | 1 | 2006 | 34 | 0.020 |
Why?
|
| Rats | 1 | 2013 | 3701 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2006 | 323 | 0.010 |
Why?
|
| Hepatitis C | 1 | 2006 | 138 | 0.010 |
Why?
|
| HIV Infections | 1 | 2013 | 2535 | 0.010 |
Why?
|